Alimera Sciences (ALIM) Files $75M IPO
More News related to IPOs
- ME911 Donates Its Services to Communities in Response to Hurricanes -- Fay, Gustav, and Hanna
- Statement From Sammy Hagar Regarding 'Right Now' Usage by John McCain:
- Inmet and Petaquilla Copper Sign Definitive Support Agreement
- Inmet and Petaquilla Copper Sign Definitive Support Agreement
- Inmet and Petaquilla Copper Sign Definitive Support Agreement
Alimera Sciences (Nasdaq: ALIM) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $75 million. The company plans to list on the NASDAQ under the stock symbol "ALIM."
The offering is being made through Credit Suisse, Citi, Cowen and Company and Leerink Swann.
Alimera Sciences is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
Stocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
